These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8987115)

  • 21. Simultaneous determination of a new anthracycline, DA-125, and its metabolites M1, M2, M3 and M4 in plasma and urine by high-performance liquid chromatography.
    Shim HJ; Lee ED; Yoon EJ; Lee SD; Kim WB; Yang J; Lee MG
    J Chromatogr B Biomed Appl; 1994 Jun; 656(2):407-14. PubMed ID: 7987494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin-induced diabetes mellitus rats.
    Park JM; Moon CH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):343-52. PubMed ID: 8896045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
    Darvari R; Boroujerdi M
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
    Kim YC; Kang HE; Lee MG
    Biopharm Drug Dispos; 2008 Jan; 29(1):51-61. PubMed ID: 18022993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats.
    Ha HA; Lee SH; Kim SH; Kim ON; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):109-28. PubMed ID: 8865375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.
    Park JH; Lee WI; Yoon WH; Park YD; Lee JS; Lee MG
    Biopharm Drug Dispos; 1998 Sep; 19(6):357-64. PubMed ID: 9737816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma/blood pharmacokinetics and metabolism after dermal exposure to para-aminophenol or para-phenylenediamine.
    Dressler WE; Appelqvist T
    Food Chem Toxicol; 2006 Mar; 44(3):371-9. PubMed ID: 16239057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro metabolism of chlorotriazines: characterization of simazine, atrazine, and propazine metabolism using liver microsomes from rats treated with various cytochrome P450 inducers.
    Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
    Toxicol Appl Pharmacol; 1999 May; 156(3):195-205. PubMed ID: 10222312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
    Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
    Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic pathway of cyanidin 3-O-beta-D-glucopyranoside in rats.
    Ichiyanagi T; Shida Y; Rahman MM; Hatano Y; Matsumoto H; Hirayama M; Konishi T
    J Agric Food Chem; 2005 Jan; 53(1):145-50. PubMed ID: 15631521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
    Lee HJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
    Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of acute renal failure on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
    Bae SK; Kwon JW; Kim WB; Lee I; Lee MG
    Biopharm Drug Dispos; 2006 Jan; 27(1):29-37. PubMed ID: 16302289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats.
    Méndez JD; Hernández Rde H
    Biomed Pharmacother; 2005 Jul; 59(6):283-9. PubMed ID: 15996850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.